


iProtics Email Formats
Biotechnology Research • Leiden, South Holland, Netherlands • 1-10 Employees
Key Contact at iProtics
Elmer Maurits
CEO / Co-founder
Company overview
| Headquarters | Leiden, South Holland, Netherlands |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Drug Discovery, Oncology, Autoimmune Disease, Drug Development, Proteasome |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
About iProtics
iProtics is a groundbreaking company dedicated to revolutionizing the treatment of cancer and auto-immune disorders. With a deep understanding of proteasomes, crucial protein-regulating complexes, iProtics aims to develop selective immunoproteasome inhibitors that target disease-causing cells while preserving the integrity of healthy tissues. Unlike current clinical drugs that indiscriminately affect both cancerous and somatic cells, iProtics' innovative approach offers a paradigm shift in therapy. Founded by a skilled team encompassing expertise in design, synthesis, drug development, and business strategies, iProtics builds upon the remarkable discoveries made by the esteemed Overkleeft group at Leiden University.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
iProtics has 1 employees across 1 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



